Drug-targeting by monoclonal antibodies

This publication has 19 references indexed in Scilit:

• Targeting of anti-cancer therapeutic agents by monoclonal antibodies
  Biochemical Society Transactions, 1986
• Cytotoxicity of a cell-reactive immunotoxin containing ricin A chain is potentiated by an anti-immunotoxin containing ricin B chain.
  The Journal of Experimental Medicine, 1984
• EX-VIVO TREATMENT OF DONOR BONE MARROW WITH ANTI-T-CELL IMMUNOTOXINS FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE
  The Lancet, 1984
• Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?
  Proceedings of the National Academy of Sciences, 1984
• Synergy of ricin A chain-containing immunotoxins and ricin B chain-containing immunotoxins in in vitro killing of neoplastic human B cells.
  Proceedings of the National Academy of Sciences, 1983
• Efficient generation in vitro, from human peripheral blood cells, of monoclonal Epstein-Barr virus transformants producing specific antibody to a variety of antigens without prior deliberate immunization.
  Proceedings of the National Academy of Sciences, 1983
• Tumor therapy with monoclonal antibodies.
  1983
• The Preparation and Cytotoxic Properties of Antibody‐Toxin Conjugates
  Immunological Reviews, 1982
• Entry of lethal doses of abrin, ricin and modeccin into the cytosol of HeLa cells
  Experimental Cell Research, 1980
• The effect in vivo of chemotherapeutic drug—antibody conjugates in two murine experimental tumor systems
  International Journal of Cancer, 1978